ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,380Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 1749

$1.83M Total Retail Price of All Prescriptions

Rank: 10 out of 1749

456 Patients Receiving at Least One Drug in Part D
19%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 988 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$161 was the average price of a prescription from this provider, compared to $143 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
TRAZODONE HCL 425 39 1 2
CITALOPRAM HBR 410 72 2 10
OLANZAPINE 401 30 3 6
LITHIUM CARBONATE 365 13 4 20
CLOZAPINE 353 0 5 11
DIVALPROEX SODIUM 338 0 6 15
DIVALPROEX SODIUM ER 324 18 7 13
HYDROXYZINE PAMOATE 317 0 R 8 43
SIMVASTATIN 265 0 9 52
ABILIFY 261 23 10 5
BENZTROPINE MESYLATE 256 0 R 11 3
LEVOTHYROXINE SODIUM 251 0 12 37
BUSPIRONE HCL 243 36 13 26
ZOLPIDEM TARTRATE 228 34 14 9
SEROQUEL XR 227 38 15 25
BUPROPION XL 225 34 16 18
TOPIRAMATE 225 18 16 29
HYDROXYZINE HCL 220 0 R 18 69
FAZACLO 202 0 19 34
INVEGA SUSTENNA 200 0 20 32
RISPERIDONE 198 33 21 1
LATUDA 197 28 22 35
FLUPHENAZINE HCL 192 0 23 36
PROPRANOLOL HCL 183 0 24 41
QUETIAPINE FUMARATE 179 37 25 4
VALPROIC ACID 174 0 26 58
HALOPERIDOL 170 13 27 21
CHLORPROMAZINE HCL 170 0 27 48
ZIPRASIDONE HCL 146 25 29 28
VENLAFAXINE HCL ER 132 21 30 17
TRIHEXYPHENIDYL HCL 132 0 R 30 33
LAMOTRIGINE 123 26 32 14
FLUOXETINE HCL 119 16 33 8
ESCITALOPRAM OXALATE 103 27 34 23
LEXAPRO 99 32 35 38
OMEPRAZOLE 99 0 35 60
CYMBALTA 95 13 37 12
SERTRALINE HCL 93 0 38 7
FLUPHENAZINE DECANOATE 88 0 39 79
BUPROPION HCL SR 85 29 40 22
METFORMIN HCL 84 0 41 63
SEROQUEL 81 0 42 24
SAPHRIS 81 0 42 56
FANAPT 77 0 44 62
GEODON 74 22 45 55
FLUVOXAMINE MALEATE 72 0 46 54
MIRTAZAPINE 70 19 47 16
PERPHENAZINE 68 0 48 44
LUNESTA 64 26 49 68
DOXEPIN HCL 58 33 50 64
DONEPEZIL HCL 56 47 51 30
INVEGA 55 0 52 45
MEDROXYPROGESTERONE ACETATE 53 0 53 197
DESMOPRESSIN ACETATE 50 0 54 89
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 26, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.